Key result
SAQ-7 demonstrates excellent internal consistency and test-retest reliability in post-MI patients.
Why the study?
The short version of the Seattle Angina Questionnaire-7 is widely used in coronary artery disease, but its use in patients post myocardial infarction is limited.
Does the SAQ-7 demonstrate valid and reliable psychometric properties for assessing health-related quality of life in patients post-myocardial infarction?
Cohort (n=258)
Yes
Does the SAQ-7 demonstrate valid and reliable psychometric properties for assessing health-related quality of life in patients post-myocardial infarction?
Effect estimate: ICC 0.94 (95% CI 0.92-0.96)
p-value: p=<.001
The SAQ-7 is a highly reliable and valid instrument for measuring health-related quality of life in stable patients following a myocardial infarction.
Supports SAQ-7 for post-MI HRQoL assessment; extends prior CAD validation in this cohort.
The short version of the Seattle Angina Questionnaire-7 (SAQ-7) is widely used in patients with coronary artery disease, but its use in patients post myocardial infarction (MI) is limited. This study aimed to validate the SAQ-7 in patients post-MI. A longitudinal cohort study was conducted with 258 stable participants with MI recruited from different outpatient cardiology clinics. Participants with cardiologist-confirmed MI, stable ≥4 weeks were included in the study, while participants with ejection fraction <40%, neurological or musculoskeletal disorders were excluded. Participants completed the SAQ-7, European quality of life-five dimensions-five levels (EQ-5D-5L), and Short Form 12 (SF-12) at baseline. Questionnaires were self-administered, and assistance was given when required. A subset of 117 participants returned 3 to 10 days later for a follow up to assess test-retest reliability. Participants completed the SAQ-7 alongside with a global rating of change scale (GRC). Cronbach alpha and intraclass correlation coefficient (ICC 2,1 ) were used to examine internal consistency and test-retest reliability, respectively. Construct validity was determined via correlations with EQ-5D-5L and SF-12 scores. The SAQ-7 demonstrated excellent internal consistency (Cronbach alpha = 0.97) and test-retest reliability (ICC 2,1 = 0.94; 95% CI: 0.92–0.96, P <.001). The SAQ-7’s measurement error was 1.76, with a minimum detectable change at 95% confidence of 4.87 points. The Bland and Altman analysis showed a mean difference of 0.75 with narrow limits of agreement. The SAQ-7 correlated strongly with EQ-5D-5L (r = -0.86, P <.001) and moderately with the SF-12 Physical ( R = 0.74, P <.001) and Mental ( R = 0.57, P <.001) components scores. No floor or ceiling effects were observed. The SAQ-7 demonstrated excellent psychometric properties in post-MI, supporting its use for health related quality of life assessment. However, these findings should be interpreted in the context of the study population and design.
No takes yet. Share an insight, caveat, or question.
Albarrati et al. (2026) conducted a cohort in Myocardial infarction (n=258). Seattle Angina Questionnaire-7 (SAQ-7) was evaluated on Test-retest reliability (ICC 0.94, 95% CI 0.92-0.96, p=<.001). The Seattle Angina Questionnaire-7 demonstrated excellent test-retest reliability (ICC 0.94; 95% CI 0.92-0.96; P<.001) and internal consistency in stable post-myocardial infarction patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: